Mast Cell Proteoglycans

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 12, 2012, Pages 950-962

  Rönnberg, Elin ^a   Melo, Fabio R ^a   Pejler, Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

mast cells; proteases; proteoglycans; secretory granules; serglycin

Indexed keywords

AGRIN; BETA ACTIN; BREVICAN; CHONDROITIN SULFATE; COLLAGEN TYPE 15; COLLAGEN TYPE 18; DYSTROGLYCAN; FIBROMODULIN; GLYCOSAMINOGLYCAN; GLYPICAN 2; GLYPICAN 6; GLYPICAN I; HEPARIN; LEPRECAN I; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; MONOCYTE CHEMOTACTIC PROTEIN 6; NEUROCAN; OSTEONECTIN; PAPILIN; PERLECAN; PROTEOGLYCAN; PROTEOGLYCAN 2; PROTEOGLYCAN 3; SERGLYCIN; SYNDECAN 3; SYNDECAN 4; SYNDECAN I; TRYPTASE; UNCLASSIFIED DRUG; VERSICAN; DRUG DERIVATIVE; HEPARIN PROTEOGLYCAN; PEPTIDE HYDROLASE; PROTEOCHONDROITIN SULFATE; SULFOTRANSFERASE; VESICULAR TRANSPORT PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BONE MARROW; ENZYME ACTIVATION; EXOCYTOSIS; EXTRACELLULAR MATRIX; GRANULE CELL; HUMAN; MAST CELL; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; STATIC ELECTRICITY; WILD TYPE; ANIMAL; METABOLISM; REVIEW; SECRETORY VESICLE;

ANIMALS; APOPTOSIS; CHONDROITIN SULFATE PROTEOGLYCANS; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; MAST CELLS; PEPTIDE HYDROLASES; PROTEOGLYCANS; SECRETORY VESICLES; SULFOTRANSFERASES; VESICULAR TRANSPORT PROTEINS;

EID: 84873051857     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412458927     Document Type: Article

References (105)

1. Åbrink M,Grujic M,Pejler G.Serglycin is essential for maturation of mast cell secretory granule.J Biol Chem. 2004;279:40897-40905.
2. Akahoshi M,Song CH,Piliponsky AM,Metz M,Guzzetta A,Åbrink M,Schlenner SM,Feyerabend TB,Rodewald HR,Pejler G, et al.Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice.J Clin Invest. 2011;121:4180-4191.
3. Alter SC,Metcalfe DD,Bradford TR,Schwartz LB.Regulation of human mast cell tryptase: effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides.Biochem J. 1987;248:821-827.
4. Avraham S,Stevens RL,Gartner MC,Austen KF,Lalley PA,Weis JH.Isolation of a cDNA that encodes the peptide core of the secretory granule proteoglycan of rat basophilic leukemia-1 cells and assessment of its homology to the human analogue.J Biol Chem. 1988;263:7292-7296.
5. Avraham S,Stevens RL,Nicodemus CF,Gartner MC,Austen KF,Weis JH.Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA.Proc Natl Acad Sci U S A. 1989;86:3763-3767.
6. Bashkin P,Razin E,Eldor A,Vlodavsky I.Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.Blood. 1990;75:2204-2212.
7. Bland CE,Ginsburg H,Silbert JE,Metcalfe DD.Mouse heparin proteoglycan: synthesis by mast cell-fibroblast monolayers during lymphocyte-dependent mast cell proliferation.J Biol Chem. 1982;257:8661-8666.
8. Bourdon MA,Oldberg A,Pierschbacher M,Ruoslahti E.Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA.Proc Natl Acad Sci U S A. 1985;82:1321-1325.
9. Bourdon MA,Shiga M,Ruoslahti E.Identification from cDNA of the precursor form of a chondroitin sulfate proteoglycan core protein.J Biol Chem. 1986;261:12534-12537.
10. Bourdon MA,Shiga M,Ruoslahti E.Gene expression of the chondroitin sulfate proteoglycan core protein PG19.Mol Cell Biol. 1987;7:33-40.
11. Braga T,Grujic M,Lukinius A,Hellman L,Åbrink M,Pejler G.Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.Biochem J. 2007;403:49-57.
12. Broide DH,Metcalfe DD,Wasserman SI.Functional and biochemical characterization of rat bone marrow derived mast cells.J Immunol. 1988;141:4298-4305.
13. Brown JK,Knight PA,Wright SH,Thornton EM,Miller HR.Constitutive secretion of the granule chymase mouse mast cell protease-1 and the chemokine, CCL2, by mucosal mast cell homologues.Clin Exp Allergy. 2003;33:132-146.
14. Chuang WL,Christ MD,Peng J,Rabenstein DL.An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides.Biochemistry. 2000;39:3542-3555.
15. Craig SS,Irani AM,Metcalfe DD,Schwartz LB.Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold.Lab Invest. 1993;69:552-561.
16. Dagälv A,Holmborn K,Kjellén L,Åbrink M.Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.J Biol Chem. 2011;286:44433-44440.
17. Dawicki W,Marshall JS.New and emerging roles for mast cells in host defence.Curr Opin Immunol. 2007;19:31-38.
18. de Vries VC,Pino-Lagos K,Nowak EC,Bennett KA,Oliva C,Noelle RJ.Mast cells condition dendritic cells to mediate allograft tolerance.Immunity. 2011;35:550-561.
19. Dudeck A,Dudeck J,Scholten J,Petzold A,Surianarayanan S,Kohler A,Peschke K,Vohringer D,Waskow C,Krieg T, et al.Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.Immunity. 2011;34:973-984.
20. Duelli A,Rönnberg E,Waern I,Ringvall M,Kolset SO,Pejler G.Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases.J Immunol. 2009;183:7073-7083.
21. Echtenacher B,Mannel DN,Hultner L.Critical protective role of mast cells in a model of acute septic peritonitis.Nature. 1996;381:75-77.
22. Ehrlich PLeipzig, Germany: Leipzig University; 1878:.
23. Ellyard JI,Simson L,Bezos A,Johnston K,Freeman C,Parish CR.Eotaxin selectively binds heparin: an interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.J Biol Chem. 2007;282:15238-15247.
24. Enerbäck L,Kolset SO,Kusche M,Hjerpe A,Lindahl U.Glycosaminoglycans in rat mucosal mast cells.Biochem J. 1985;227:661-668.
25. Feyerabend TB,Li JP,Lindahl U,Rodewald HR.Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells.Nat Chem Biol. 2006;2:195-196.
26. Fillion GM,Slorach SA,Uvnas B.The release of histamine, heparin and granule protein from rat mast cells treated with compound 48-80 in vitro.Acta Physiol Scand. 1970;78:547-560.
27. Flaumenhaft R,Moscatelli D,Rifkin DB.Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor.J Cell Biol. 1990;111:1651-1659.
28. Forsberg E,Pejler G,Ringvall M,Lunderius C,Tomasini-Johansson B,Kusche-Gullberg M,Eriksson I,Ledin J,Hellman L,Kjellén L.Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme.Nature. 1999;400:773-776.
29. Ghildyal N,Friend DS,Stevens RL,Austen KF,Huang C,Penrose JF,Sali A,Gurish MF.Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood.J Exp Med. 1996;184:1061-1073.
30. Ha HC,Snyder SH.Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.Proc Natl Acad Sci U S A. 1999;96:13978-13982.
31. Hallgren J,Bäckström S,Estrada S,Thuveson M,Pejler G.Histidines are critical for heparin-dependent activation of mast cell tryptase.J Immunol. 2004;173:1868-1875.
32. Hallgren J,Karlson U,Poorafshar M,Hellman L,Pejler G.Mechanism for activation of mouse mast cell tryptase: dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6.Biochemistry. 2000;39:13068-13077.
33. Hallgren J,Lindahl S,Pejler G.Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.J Mol Biol. 2005;345:129-139.
34. Hallgren J,Spillmann D,Pejler G.Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin.J Biol Chem. 2001;276:42774-42781.
35. Henningsson F,Hergeth S,Cortelius R,Åbrink M,Pejler G.A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components.Febs J. 2006;273:4901-4912.
36. Henningsson F,Ledin J,Lunderius C,Wilén M,Hellman L,Pejler G.Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing.Biol Chem. 2002;383:793-801.
37. Henningsson F,Yamamoto K,Saftig P,Reinheckel T,Peters C,Knight SD,Pejler G.A role for cathepsin E in the processing of mast-cell carboxypeptidase A.J Cell Sci. 2005;118:2035-2042.
38. Hill M.Secretion of heparin by mast cells.Nature. 1957;180:654-655.
39. Holmgren H,Wilander O.Beitrag zur Kentnis der Chemie und Funktion der Ehrlichschen Mastzellen. Z. Mikr. Anat.Forsch. 1937;:42.
40. Horner AA.Macromolecular heparin from rat skin: isolation, characterization, and depolymerization with ascorbate.J Biol Chem. 1971;246:231-239.
41. Humphries DE,Wong GW,Friend DS,Gurish MF,Qiu WT,Huang C,Sharpe AH,Stevens RL.Heparin is essential for the storage of specific granule proteases in mast cells.Nature. 1999;400:769-772.
42. Jorpes E,Holmgren H.,Wilander O.Über das Vorkommen von Heparin in den Gefässwänden und in den Augen. Ein Beitrag zur Physiologie der Ehrlichschen Mastzellen. Z. Mikr. Anat.Forsch. 1937;:42.
43. Kalesnikoff J,Galli SJ.New developments in mast cell biology.Nat Immunol. 2008;9:1215-1223.
44. Kjellén L.Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology.Biochem Soc Trans. 2003;31:340-342.
45. Kjellén L,Pettersson I,Lillhager P,Steen ML,Pettersson U,Lehtonen P,Karlsson T,Ruoslahti E,Hellman L.Primary structure of a mouse mastocytoma proteoglycan core protein.Biochem J. 1989;263:105-113.
46. Kusche-Gullberg M,Eriksson I,Pikas DS,Kjellén L.Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes.J Biol Chem. 1998;273:11902-11907.
47. Lagunoff D,Phillips MT,Iseri OA,Benditt EP.Isolation and preliminary characterization of rat mast cell granules.Lab Invest. 1964;13:1331-1344.
48. Lee DM,Friend DS,Gurish MF,Benoist C,Mathis D,Brenner MB.Mast cells: a cellular link between autoantibodies and inflammatory arthritis.Science. 2002;297:1689-1692.
49. Levi-Schaffer F,Austen KF,Caulfield JP,Hein A,Bloes WF,Stevens RL.Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.J Immunol. 1985;135:3454-3462.
50. Lundequist A,Pejler G.Biological implications of preformed mast cell mediators.Cell Mol Life Sci. 2011;68:965-975.
51. Malaviya R,Ikeda T,Ross E,Abraham SN.Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.Nature. 1996;381:77-80.
52. Maurer M,Wedemeyer J,Metz M,Piliponsky AM,Weller K,Chatterjea D,Clouthier DE,Yanagisawa MM,Tsai M,Galli SJ.Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.Nature. 2004;432:512-516.
53. Melo FR,Grujic M,Spirkoski J,Calounova G,Pejler G.Serglycin proteoglycan promotes apoptotic versus necrotic cell death in mast cells.J Biol Chem. 2012;287:18142-18152.
54. Melo FR,Lundequist A,Calounova G,Wernersson S,Pejler G.Lysosomal membrane permeabilization induces cell death in human mast cells.Scand J Immunol. 2011;74:354-362.
55. Melo FR,Waern I,Rönnberg E,Åbrink M,Lee DM,Schlenner SM,Feyerabend TB,Rodewald HR,Turk B,Wernersson S, et al.A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.J Biol Chem. 2011;286:5423-5433.
56. Metcalfe DD,Baram D,Mekori YA.Mast cells.Physiol Rev. 1997;77:1033-1079.
57. Metcalfe DD,Lewis RA,Silbert JE,Rosenberg RD,Wasserman SI,Austen KF.Isolation and characterization of heparin from human lung.J Clin Invest. 1979;64:1537-1543.
58. Metcalfe DD,Smith JA,Austen KF,Silbert JE.Polydispersity of rat mast cell heparin: implications for proteoglycan assembly.J Biol Chem. 1980;255:11753-11758.
59. Nilsson G,Blom T,Kusche-Gullberg M,Kjellén L,Butterfield JH,Sundstrom C,Nilsson K,Hellman L.Phenotypic characterization of the human mast-cell line HMC-1.Scand J Immunol. 1994;39:489-498.
60. Ögren S,Lindahl U.Degradation of heparin in mouse mastocytoma tissue.Biochem J. 1971;125:1119-1129.
61. Ohtake S,Kondo S,Morisaki T,Matsumura K,Kimata K,Habuchi O.Expression of sulfotransferases involved in the biosynthesis of chondroitin sulfate E in the bone marrow derived mast cells.Biochim Biophys Acta. 2008;1780:687-695.
62. Ohtake-Niimi S,Kondo S,Ito T,Kakehi S,Ohta T,Habuchi H,Kimata K,Habuchi O.Mice deficient in N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase are unable to synthesize chondroitin/dermatan sulfate containing N-acetylgalactosamine 4,6-bissulfate residues and exhibit decreased protease activity in bone marrow-derived mast cells.J Biol Chem. 2010;285:20793-20805.
63. Oschatz C,Maas C,Lecher B,Jansen T,Bjorkqvist J,Tradler T,Sedlmeier R,Burfeind P,Cichon S,Hammerschmidt S, et al.Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo.Immunity. 2011;34:258-268.
64. Pejler G,Åbrink M,Ringvall M,Wernersson S.Mast cell proteases.Adv Immunol. 2007;95:167-255.
65. Pejler G,Berg L.Regulation of rat mast cell protease 1 activity: protease inhibition is prevented by heparin proteoglycan.Eur J Biochem. 1995;233:192-199.
66. Pejler G,Karlström A.Thrombin is inactivated by mast cell secretory granule chymase.J Biol Chem. 1993;268:11817-11822.
67. Pejler G,Maccarana M.Interaction of heparin with rat mast cell protease 1.J Biol Chem. 1994;269:14451-14456.
68. Pejler G,Rönnberg E,Waern I,Wernersson S.Mast cell proteases: multifaceted regulators of inflammatory disease.Blood. 2010;115:4981-4990.
69. Pejler G,Sadler JE.Mechanism by which heparin proteoglycan modulates mast cell chymase activity.Biochemistry. 1999;38:12187-12195.
70. Pereira PJ,Bergner A,Macedo-Ribeiro S,Huber R,Matschiner G,Fritz H,Sommerhoff CP,Bode W.Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.Nature. 1998;392:306-311.
71. Proudfoot AE.The biological relevance of chemokine-proteoglycan interactions.Biochem Soc Trans. 2006;34:422-426.
72. Razin E,Ihle JN,Seldin D,Mencia-Huerta JM,Katz HR,LeBlanc PA,Hein A,Caulfield JP,Austen KF,Stevens RL.Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.J Immunol. 1984;132:1479-1486.
73. Razin E,Stevens RL,Akiyama F,Schmid K,Austen KF.Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate.J Biol Chem. 1982;257:7229-7236.
74. Ren S,Sakai K,Schwartz LB.Regulation of human mast cell beta-tryptase: conversion of inactive monomer to active tetramer at acid pH.J Immunol. 1998;160:4561-4569.
75. Ringvall M,Ledin J,Holmborn K,van Kuppevelt T,Ellin F,Eriksson I,Olofsson AM,Kjellén L,Forsberg E.Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.J Biol Chem. 2000;275:25926-25930.
76. Ringvall M,Rönnberg E,Wernersson S,Duelli A,Henningsson F,Åbrink M,Garcia-Faroldi G,Fajardo I,Pejler G.Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan.J Allergy Clin Immunol. 2008;121:1020-1026.
77. Robinson HC,Horner AA,Höök M,Ögren S,Lindahl U.A proteoglycan form of heparin and its degradation to single-chain molecules.J Biol Chem. 1978;253:6687-6693.
78. Rönnberg E,Calounova G,Pejler G.Mast cells express tyrosine hydroxylase and store dopamine in a serglycin-dependent manner.Biol Chem. 2012;393:107-112.
79. Sayama S,Iozzo RV,Lazarus GS,Schechter NM.Human skin chymotrypsin-like proteinase chymase: subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.J Biol Chem. 1987;262:6808-6815.
80. Schwartz LB,Austen KF.Enzymes of the mast cell granule.J Invest Dermatol. 1980;74:349-353.
81. Schwartz LB,Bradford TR.Regulation of tryptase from human lung mast cells by heparin: stabilization of the active tetramer.J Biol Chem. 1986;261:7372-7379.
82. Schwartz LB,Lewis RA,Austen KF.Tryptase from human pulmonary mast cells. Purification and characterization.J Biol Chem. 1981;256:11939-11943.
83. Schwartz LB,Riedel C,Caulfield JP,Wasserman SI,Austen KF.Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells.J Immunol. 1981;126:2071-2078.
84. Sebollela A,Cagliari TC,Limaverde GS,Chapeaurouge A,Sorgine MH,Coelho-Sampaio T,Ramos CH,Ferreira ST.Heparin-binding sites in granulocyte-macrophage colony-stimulating factor: localization and regulation by histidine ionization.J Biol Chem. 2005;280:31949-31956.
85. Seldin DC,Austen KF,Stevens RL.Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells.J Biol Chem. 1985;260:11131-11139.
86. Serafin WE,Dayton ET,Gravallese PM,Austen KF,Stevens RL.Carboxypeptidase A in mouse mast cells: identification, characterization, and use as a differentiation marker.J Immunol. 1987;139:3771-3776.
87. Serafin WE,Katz HR,Austen KF,Stevens RL.Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells.J Biol Chem. 1986;261:15017-15021.
88. Skliris A,Happonen KE,Terpos E,Labropoulou V,Borset M,Heinegard D,Blom AM,Theocharis AD.Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.Eur J Immunol. 2011;41:437-449.
89. Slorach SA.Histamine and heparin release from isolated rat mast cells exposed to compound 48-80.Acta Physiol Scand. 1971;82:91-97.
90. Soucek L,Lawlor ER,Soto D,Shchors K,Swigart LB,Evan GI.Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.Nat Med. 2007;13:1211-1218.
91. Stevens RL,Avraham S,Gartner MC,Bruns GA,Austen KF,Weis JH.Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells.J Biol Chem. 1988;263:7287-7291.
92. Stevens RL,Lee TD,Seldin DC,Austen KF,Befus AD,Bienenstock J.Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans.J Immunol. 1986;137:291-295.
93. Stevens RL,Otsu K,Austen KF.Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell.J Biol Chem. 1985;260:14194-14200.
94. Sun J,Sukhova GK,Wolters PJ,Yang M,Kitamoto S,Libby P,MacFarlane LA,Mallen-St Clair J,Shi GP.Mast cells promote atherosclerosis by releasing proinflammatory cytokines.Nat Med. 2007;13:719-724.
95. Tanino Y,Coombe DR,Gill SE,Kett WC,Kajikawa O,Proudfoot AE,Wells TN,Parks WC,Wight TN,Martin TR, et al.Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.J Immunol. 2010;184:2677-2685.
96. Tantravahi RV,Stevens RL,Austen KF,Weis JH.A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans.Proc Natl Acad Sci U S A. 1986;83:9207-9210.
97. Tchougounova E,Pejler G.Regulation of extravascular coagulation and fibrinolysis by heparin-dependent mast cell chymase.FASEB J. 2001;15:2763-2765.
98. Thompson HL,Schulman ES,Metcalfe DD.Identification of chondroitin sulfate E in human lung mast cells.J Immunol. 1988;140:2708-2713.
99. Tsai M,Takeishi T,Thompson H,Langley KE,Zsebo KM,Metcalfe DD,Geissler EN,Galli SJ.Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.Proc Natl Acad Sci U S A. 1991;88:6382-6386.
100. Urata H,Kinoshita A,Misono KS,Bumpus FM,Husain A.Identification of a highly specific chymase as the major angiotensin II- forming enzyme in the human heart.J Biol Chem. 1990;265:22348-22357.
101. Wang B,Jia J,Zhang X,Zcharia E,Vlodavsky I,Pejler G,Li JP.Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin.J Allergy Clin Immunol. 2011;128:1310-1317.e8.
102. Yu M,Tsai M,Tam SY,Jones C,Zehnder J,Galli SJ.Mast cells can promote the development of multiple features of chronic asthma in mice.J Clin Invest. 2006;116:1633-1641.
103. Yurt RW,Leid RW,Austen KF.Native heparin from rat peritoneal mast cells.J Biol Chem. 1977;252:518-521.
104. Yurt RW,Leid RW,Spragg J,Austen KF.Immunologic release of heparin from purified rat peritoneal mast cells.J Immunol. 1977;118:1201-1207.
105. Zcharia E,Jia J,Zhang X,Baraz L,Lindahl U,Peretz T,Vlodavsky I,Li JP.Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.PloS One. 2009;4:e5181.